Anthracycline-related cardiotoxicity in breast cancer patients carrying mutational signature of homologous recombination deficiency (HRD)

被引:0
|
作者
Incorvaia, L. [1 ]
Fiorino, A. [2 ]
Gori, S. [3 ]
Cinieri, S. [4 ]
Curigliano, G. [5 ]
Toss, A. [6 ]
Cortesi, L. [7 ]
Ricciardi, G. R. R. [8 ]
Chiari, R. [9 ]
Peri, M. [1 ]
Brando, C. [2 ]
Russo, T. D. Bazan [10 ]
Gristina, V. [2 ]
Galvano, A. [1 ]
Damerino, G. [11 ]
Carreca, I. U. [1 ]
Novo, G. [11 ]
Badalamenti, G. [1 ]
Bazan, V. [12 ]
Russo, A. [2 ]
机构
[1] Univ Palermo, Dept Surg Oncol Oral Sci, Palermo, Italy
[2] Univ Palermo, Med Oncol Sect, Surg Oncol & Oral Sci Dept, Palermo, Italy
[3] IRCCS Osped Sacro Cuore Don Calabria, Med Oncol Dept, Verona, Italy
[4] Osped A Perrino, Med Oncol Dept, Brindisi, Italy
[5] IEO Ist Europeo Oncol, Early Drug Dev Innovat Therapies Div, Milan, Italy
[6] Azienda Osped Univ Policlin Modena, Dept Oncol & Haematol, Modena, Italy
[7] Azienda Osped Univ Policlin Modena, Oncol & Haematol Dept, Modena, Italy
[8] Osped Papardo, Med Oncol Dept, Ctr Oncol, Messina, Italy
[9] Azienda Osped Osped Riuniti Marche Nord, Med, Pesaro, Italy
[10] Univ Palermo, Sect Med Oncol, Dept Surg Oncol & Oral Sci, Palermo, Italy
[11] Univ Palermo, Internal Med & Med Specialties PROMISE, Dept Hlth Promot Mother & Child Care, Palermo, Italy
[12] Univ Palermo, Sect Med Oncol, Dept Biomed Neurosci & Adv Diag Bi N D, Palermo, Italy
关键词
D O I
10.1016/j.annonc.2022.07.1030
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
904MO
引用
收藏
页码:S961 / S962
页数:2
相关论文
共 50 条
  • [31] Selecting patients with oligo-metastatic breast cancer harboring homologous recombination deficiency (HRD) for intensified chemotherapy: The OLIGO-study
    Steenbruggen, T. G.
    Scholten, A. N.
    Vrancken-Peeters, M-J. T.
    Mandjes, I. A.
    Holtkamp, M.
    Wesseling, J.
    Linn, S. C.
    Sonke, G. S.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [32] Anthracycline-related cardiotoxicity in older patients with acute myeloid leukemia: a Young SIOG review paper
    Neuendorff, Nina Rosa
    Loh, Kah Poh
    Mims, Alice S.
    Christofyllakis, Konstantinos
    Soo, Wee-Kheng
    Bolukbasi, Bediha
    Onoro-Algar, Carlos
    Hundley, William G.
    Klepin, Heidi D.
    [J]. BLOOD ADVANCES, 2020, 4 (04) : 762 - 775
  • [33] Hypertension Susceptibility Loci are Associated with Anthracycline-related Cardiotoxicity in Long-term Childhood Cancer Survivors
    Hildebrandt, Michelle A. T.
    Reyes, Monica
    Wu, Xifeng
    Pu, Xia
    Thompson, Kara A.
    Ma, Jianzhong
    Landstrom, Andrew P.
    Morrison, Alanna C.
    Ater, Joann L.
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [34] Homologous recombination deficiency in triple negative breast cancer
    Belli, Carmen
    Duso, Bruno Achutti
    Ferraro, Emanuela
    Curigliano, Giuseppe
    [J]. BREAST, 2019, 45 : 15 - 21
  • [35] Homologous Recombination Deficiency in Breast Cancer: A Clinical Review
    den Brok, Wendie D.
    Schrader, Kasmintan A.
    Sun, Sophie
    Tinker, Anna V.
    Zhao, Eric Yang
    Aparicio, Samuel
    Gelmon, Karen A.
    [J]. JCO PRECISION ONCOLOGY, 2017, 1 : 1 - 13
  • [36] Clinical Utility of Homologous Recombination Deficiency (HRD) Profiling in Ovarian Cancer: An Indian Experience
    Bahadur, U.
    Ravichandran, A.
    Basu, S.
    Nayanala, S.
    Vishwanath, D.
    Muniyappa, N.
    Neelagandan, B. G. K.
    Ramkumar, A. N. J. A.
    Sajjad, S.
    Nair, R. H. J. J.
    Krishnan, G.
    Ramanathan, V. G. R. A.
    Chatterjee, A.
    Sridharan, S.
    Phalke, S.
    Veeramachaneni, V.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2023, 25 (11): : S106 - S106
  • [37] Homologous recombination deficiency (HRD) score and niraparib efficacy in high grade ovarian cancer
    Haluska, P.
    Timms, K. M.
    AlHilli, M.
    Wang, Y.
    Hartman, A. M.
    Jones, J.
    Gutin, A.
    Sangale, Z.
    Neff, C.
    Lynchbury, J.
    Rudolph-Owen, L.
    Becker, M. A.
    Agarwal, S.
    Wilcoxen, K. M.
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 : 72 - 73
  • [38] Pathological complete response (pCR) association with a novel homologous recombination deficiency HRD signature (HRDsig) in patients with triple-negative breast cancer (TNBC) receiving neoadjuvant therapy (Tx)
    Gupta, Tanya
    Graf, Ryon P.
    Schrock, Alexa B.
    Madison, Russell
    Ross, Jeffrey S.
    Levy, Mia Alyce
    Quintanilha, Julia
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [39] A proteomics-based approach to identify biomarker profiles of homologous recombination deficiency (HRD) in breast cancer cell lines
    Prime, John E.
    Unwin, Louise
    Hunter, Jill
    Allum, Richard
    Nickson, Janice A.
    Rowlinson, Rachel
    Giavara, Sabrina
    Lueck, Carsten
    Lau, Alan
    O'Connor, Mark J.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [40] Hypertension Susceptibility Loci are Associated with Anthracycline-related Cardiotoxicity in Long-term Childhood Cancer Survivors
    Michelle A. T. Hildebrandt
    Monica Reyes
    Xifeng Wu
    Xia Pu
    Kara A. Thompson
    Jianzhong Ma
    Andrew P. Landstrom
    Alanna C. Morrison
    Joann L. Ater
    [J]. Scientific Reports, 7